Literature DB >> 229856

Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents.

J W Lown, H H Chen, J A Plambeck, E M Acton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 229856     DOI： 10.1016/0006-2952(79)90027-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  12 in total

1.  The electrochemistry of quinizarin revealed through its mediated reduction of oxygen.

Authors:  Christopher Batchelor-McAuley; Ivan B Dimov; Leigh Aldous; Richard G Compton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-22       Impact factor: 11.205

Review 2.  Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  L M Hollingshead; D Faulds
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

3.  The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients.

Authors:  M A Graham; D R Newell; B J Foster; A H Calvert
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin.

Authors:  O Cantoni; P Sestili; F Cattabeni; C Geroni; M Grandi; F C Giuliani
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Electron affinities of p-benzoquinone, p-benzoquinone imine and p-benzoquinone diimine, and spin densities of their p-benzosemiquinones computed by several quantum chemical models.

Authors:  Y H Mariam; L Chantranupong
Journal:  J Comput Aided Mol Des       Date:  1997-07       Impact factor: 3.686

6.  Comparative cytotoxicities of various morpholinyl anthracyclines.

Authors:  D G Streeter; D L Taylor; E M Acton; J H Peters
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 7.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

8.  Relative cardiotoxicity and cytotoxicity of anthraquinonyl glucosaminosides.

Authors:  J W Banning; H N Abramson; H C Wormser; J D Wu; T H Corbett
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Effects of 5-iminodaunorubicin on nucleoli of rats.

Authors:  J H Peters; M J Evans; R A Jensen; E M Acton
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 10.  The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.

Authors:  Ashkan Emadi; Judith E Karp
Journal:  Pharmacogenomics       Date:  2012-08       Impact factor: 2.533
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.